Companies /Healthcare

Medpace Holdings Inc

NASDAQ: MEDP Diagnostics & Research
$611.57
▼ $7.48 (−1.21%) today
Markets closed · 5:47pm ET
Today · % change

24/7 Wall St. View

Fundamentals

Market Cap
$17.1B
P/E Ratio
36.0
Profit Margin
17.7%
Revenue (TTM)
$2.8B
EPS (TTM)
$17.05
52-Week Range
$373 – $678
Street Target
$581.83

About Medpace

Medpace Holdings Inc is a key player in the field of clinical research, offering comprehensive development services for drugs and medical devices. With a global footprint spanning North America, Europe, and Asia, the company supports the entire clinical development journey from Phase I through Phase IV across various therapeutic areas. Medpace caters to the pharmaceutical, biotechnology, and medical device industries, providing services such as project management, regulatory affairs, clinical monitoring, and more. Founded in 1992 and headquartered in Cincinnati, Ohio, Medpace is dedicated to advancing medical science through its specialized services.

MEDP Coverage